# § 349.70   Labeling of ophthalmic hypertonicity drug products.

(a) *Statement of identity.* The labeling of the product contains the established name of the drug, if any, and identifies the product as a “hypertonicity” (select one of the following: “eye” or “ophthalmic”) “(insert dosage form, e.g., drops).” 


(b) *Indications.* The labeling of the product states, under the heading “Indications,” the following phrase: “For the temporary relief of corneal edema.” 


(c) *Warnings.* In addition to the warnings in § 349.50, the labeling of the product contains the following warnings under the heading “Warnings” for products containing any ingredient identified in § 349.16: 


(1) “Do not use this product except under the advice and supervision of a doctor. If you experience eye pain, changes in vision, continued redness or irritation of the eye, or if the condition worsens or persists, consult a doctor.” 


(2) “This product may cause temporary burning and irritation on being instilled into the eye.” 


(3) “If solution changes color or becomes cloudy, do not use.” 


(d) *Directions.* The labeling of the product contains the following information under the heading “Directions”: Instill 1 or 2 drops in the affected eye(s) every 3 or 4 hours, or as directed by a doctor. 




